Clinical Trial Update: Empagliflozin Treatment in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating empagliflozin in kidney transplant recipients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Kidney Transplantation

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Kidney Transplant, Chronic Kidney Disease | Phase 4 | Status: RECRUITING